Get the Stockscreener App
3.07
7.81%
-0.26
Nyxoah Sa stock is traded at $3.07, with a volume of 24,486.
It is down -7.81% in the last 24 hours and up +7.34% over the past month.
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
See More
Previous Close:
$3.33
Open:
$3.21
24h Volume:
24,486
Relative Volume:
0.51
Market Cap:
$134.04M
Revenue:
$11.51M
Net Income/Loss:
$-101.84M
P/E Ratio:
-1.1492
EPS:
-2.6714
Net Cash Flow:
$-82.98M
1W Performance:
+3.37%
1M Performance:
+7.34%
6M Performance:
-47.88%
1Y Performance:
-48.66%
1-Day Range:
$3.00
$3.23
1-Week Range:
$3.00
$3.35
52-Week Range:
$2.76
$8.64
Nyxoah Sa Stock (NYXH) Company Profile
Name
Nyxoah Sa
Sector
Industry
Phone
-
Address
-
Compare NYXH vs ISRG, BDX, MDLN, ALC, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NYXH
Nyxoah Sa
|
3.07 | 145.40M | 11.51M | -101.84M | -82.98M | -2.6714 |
ISRG
Intuitive Surgical Inc
|
431.87 | 148.77B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
147.51 | 39.44B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
38.55 | 33.19B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
63.78 | 30.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
203.79 | 28.83B | 5.54B | 1.52B | 1.74B | 10.37 |
Nyxoah Sa Stock (NYXH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-31-23 | Initiated | H.C. Wainwright | Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Apr-21-22 | Initiated | Oppenheimer | Outperform |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Dec-21-21 | Resumed | Cantor Fitzgerald | Overweight |
| Jul-28-21 | Initiated | Cantor Fitzgerald | Overweight |
View All
Nyxoah Sa Stock (NYXH) Latest News
Earnings Call Summary | Nyxoah SA(NYXH.US) Q1 2026 Earnings Conference - Moomoo
Nyxoah SA reports results for the quarter ended March 31Earnings Summary - TradingView
Nyxoah Q1 Earnings Call Highlights - Yahoo Finance
Nyxoah SA (NYXH) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Earnings call transcript: Nyxoah Q1 2026 sees strong U.S. growth, stock dips - Investing.com
Nyxoah Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga
Nyxoah Calls June 10 Shareholder Meetings and Files Q1 2026 Results - TipRanks
Nyxoah (Nasdaq: NYXH) posts Q1 2026 surge in revenue but flags funding risk - Stock Titan
Nyxoah : Q1 Report 2026 - marketscreener.com
Sleep apnea device maker Nyxoah posts €6.4m sales, €20.5m loss - Stock Titan
Stifel cuts Nyxoah stock rating on reimbursement challenges - Investing.com
symbol__ Stock Quote Price and Forecast - CNN
Stifel Maintains Nyxoah SA(NYXH.US) With Buy Rating, Cuts Target Price to $10 - Moomoo
Nyxoah to let registered holders follow June 10 meetings by video - Stock Titan
Invitation to attend the annual and the extraordinary - GlobeNewswire
Nyxoah SA (NYXH) may report negative earnings: Know the trend ahead of next week's release - MSN
Earnings Preview: Nyxoah SA to Report Financial Results on May 12 - 富途牛牛
Nyxoah SA (NYXH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance
How The Nyxoah (ENXTBR:NYXH) Narrative Is Shifting With CMS Codes And Trimmed Targets - Yahoo Finance
Nyxoah (NYXH) Earnings Date and Reports 2026 - MarketBeat
Nyxoah : to Participate in the Bank of America 2026 Healthcare Conference - marketscreener.com
Latest NYXH NewsNyxoah Announces Pricing of Nasdaq Public O... - Stock Titan
Nyxoah to Participate in the Bank of America 2026 Healthcare Conference - The Manila Times
Nyxoah (NYXH) Jefferies 2024 Global Healthcare Conference Summary - Quartr
Nyxoah (NYXH) 2024 Cantor Fitzgerald Global Healthcare Conference Summary - Quartr
Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026 - Sahm
Nyxoah sets May 12 for Q1 results and 4:30 p.m. ET webcast - Stock Titan
Nyxoah SA Stock Rises Pre-Market After CMS Raises Reimbursement For Sleep Disorder Therapy - MSN
Nyxoah (NYXH) Stock Forecast & Price Target - Investing.com
Nyxoah SA (NYXH) Stock: Directional Bias Review | Q4 2025: EPS Misses ViewsSubscription Growth - Xã Châu Thành
NYXH (Nyxoah SA Ordinary Shares) posts 121 percent year over year revenue growth, shares rise 3.21 percent.EBITDA Margin - Cổng thông tin điện tử tỉnh Tây Ninh
Nyxoah SA (NYXH) Stock Position Trade (Grinds Higher) 2026-04-20Retail Picks - newser.com
Baird lowers its price target on Nyxoah SA (NYXH) to $4.62 from $5.87 - MSN
Nyxoah SA (NYXH) Stock Analysis: Exploring a 208% Potential Upside in the Medical Tech Sector - DirectorsTalk Interviews
Nyxoah's Stock Rebounds 12% in Session After a 52% Annual Decline - Idéal Investisseur
Aug PreEarnings: Is Nyxoah SA forming bullish engulfing patterns2026 Price Momentum & AI Powered Trade Plan Recommendations - baoquankhu1.vn
How do market conditions affect Nyxoah SA (NYXH) Stock | Price at $2.87, Up 0.35%Community Volume Signals - Xã Thanh Hà
Nyxoah SA (NYXH) reports Q4 loss, misses revenue estimates - MSN
Baird Maintains Nyxoah SA(NYXH.US) With Hold Rating, Cuts Target Price to $4.62 - 富途牛牛
Today's Analyst Ratings for Nyxoah (NYXH): Stock Price Target Lo - GuruFocus
Stifel cuts Nyxoah stock price target to $8 on valuation review - Investing.com Canada
Stifel cuts Nyxoah stock price target to $8 on valuation review By Investing.com - Investing.com South Africa
Stifel Maintains Nyxoah SA(NYXH.US) With Buy Rating, Cuts Target Price to $8 - 富途牛牛
Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024 - NTB Kommunikasjon
Market Overview: Can Nyxoah SA expand into new marketsPortfolio Gains Report & Consistent Profit Alerts - baoquankhu1.vn
Growth Review: Is now the right time to enter Nyxoah SA2026 Levels & AI Powered Market Trend Analysis - baoquankhu1.vn
Aug Breakouts: Will Nyxoah SA benefit from AI trendsWeekly Gains Report & AI Based Buy and Sell Signals - baoquankhu1.vn
NYXH Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Nyxoah Sa Stock (NYXH) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.05%
3.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):